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ABSTRACT
Direct site-specific biotinylation of RNA molecules
was achieved by specific transcription mediated by
unnatural base pairs. Unnatural base pairs between
2-amino-6-(2-thienyl)purine (denoted by s) and
2-oxo(1H)pyridine (denoted by y), or 2-amino-6-
(2-thiazolyl)purine (denoted as v) and y specifically
function in T7 transcription. Using these unnatural
base pairs, the substrate of biotinylated-y (Bio-yTP)
was selectively incorporated into RNA, opposite s or
v in the DNA templates, by T7 RNA polymerase. This
method was applied to the immobilization of an RNA
aptamer on sensor chips, and the aptamer accurately
recognized its target protein. This direct site-specific
biotinylation will provide a tool for RNA-based
biotechnologies.
INTRODUCTION
RNA molecules are frequently labeled with biotin for immob-
ilization on avidin supports. In addition, the biotin in RNA
molecules functions as a chemiluminescent marker using
streptavidin coupled to alkaline phosphatase, to detect the
RNA molecules and their interaction with target molecules.
Several biotinylation methods for RNA have been reported.
For example, biotin-modiﬁed substrates, such as biotinylated
UTP or CTP, are available for the direct biotinylation of RNA
during transcription (1). However, it is difﬁcult to control
the labeling position with this simple method, and this
often alters the biological function of the labeled RNA.
Chemical biotinylation of RNA at the 30 or 50end of the mole-
cule with biotin-conjugated hydrazide (2–4) was developed to
circumvent this problem. RNA can also be biotin-labeled at
the 50 end by a one-step transcription procedure, using N6-
biotin derivatives of AMP as transcription initiators under the
T7 f2.5 promoter (5) or biotinyl-guanosine 50-monophosphate
under the conventional T7 promoter (6). Another attractive
method would be direct site-speciﬁc biotinylation at the
desired positions by transcription using unnatural base pairs.
We recently developed unnatural base pairs between
2-amino-6-(2-thienyl)purine (denoted by s) and 2-oxo(1H)-
pyridine (denoted by y) (7,8) or 2-amino-6-(2-thiazolyl)-
purine (denoted as v) and y (Figure 1A and B) (9). These
unnatural base pairs function in transcription, and the substrate
of y (yTP) can be site-speciﬁcally incorporated into RNA,
opposite s or v in templates, by T7 RNA polymerase. In
addition, position 5 of y can be modiﬁed to introduce various
functional groups via the nucleoside of 5-iodo-2-oxo-
(1H)pyridine (5-iodo-y) (10,11). Therefore, these unnatural
base pairs could be used in the direct site-speciﬁc biotinylation
of RNA molecules. Here, we report the synthesis of the sub-
strate of biotinylated-y (Bio-yTP, Figure 1C), the incorpora-
tionofBio-yintoRNA byT7transcription,andtheapplication
of this method to the immobilization of an RNA aptamer.
MATERIALS AND METHODS
General
Reagents and solvents were purchased from standard suppliers
and used without further puriﬁcation. Reactions were moni-
tored by thin-layer chromatography (TLC), using 0.25-mm
silica gel 60 plates impregnated with 254 nm ﬂuorescent indi-
cator (Merck).
1H-NMR (270 MHz),
13C-NMR (68 MHz)
and
31P-NMR (109 MHz) spectra were recorded on a JEOL
EX270 magnetic resonance spectrometer. Puriﬁcation of
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doi:10.1093/nar/gni128nucleosides was performed on a Gilson HPLC system with
a preparative C18 column (Waters m-Bondsphere f 19 ·
150 mm). Triphosphates were puriﬁed on a DEAE-
Sephadex A-25 column (300 · 15 mm), and the ﬁnal puriﬁca-
tion was achieved using a Gilson HPLC system with an
analytical column (Synchropak RPP, 250 · 4.6 mm, Eichrom
Technologies). High resolution mass spectra (HRMS) and
electrospray ionization mass spectra (ESI-MS) were recorded
on a JEOL HX-110 mass spectrometer and a Waters micro-
mass ZMD 4000 spectrometer equipped with a Waters 2690
LC system, respectively.
3-(Dichloroacetamido)-1-propyne (1)
Dichloroacetylchloride (2.12 ml, 22 mmol, 1.1 eq.) was added
to a solution of propargylamine (1.37 ml, 20 mmol) and
NaHCO3 (2.02 g, 24 mmol, 1.2 eq.) in 40 ml of dry
CH2Cl2, and the solution was stirred at room temperature
for 3 h. The reaction mixture was washed once with 5%
NaHCO3 (aq) and twice with saturated NaCl (aq). The organic
phase was dried over Na2SO4 and evaporated in vacuo to give
a brown oil of 1 (2.67 g, 16.1 mmol, 81%), which was solid at
room temperature.
1H-NMR (270 MHz, CDCl3) d (p.p.m.)
6.62 (bs, 1H), 5.88 (s, 1H), 4.06 (dd, 2H, J ¼ 2.6, 5.3 Hz),
2.26 (t, 1H, J ¼ 2.6 Hz).
13C-NMR (68 MHz, CDCl3) d
(p.p.m.) 163.54, 77.80, 72.83, 65.92, 30.28. HRMS (FAB,
3-NBA matrix) for C5H6ONCl2 (M + 1): calcd, 165.9826;
found, 165.9852.
3-(b-D-Ribofuranosyl)-5-[3-(dichloroacetamido)-
1-propynyl]-2-oxo(1H)pyridine (3)
Compound 2 (283 mg, 0.80 mmol) (10) was co-evaporated
successively with dry acetonitrile and dry toluene (three times
each). Tetrakis(triphenylphosphine)palladium(0) (46.3 mg,
0.040 mmol, 0.05 eq.) and CuI (24.4 mg, 0.128 mmol, 0.16
eq.) were added and dissolved in 3.6 ml of dry DMF, and then
triethylamine (167 ml, 1.20 mmol, 1.5 eq.) was added. To the
solutionwasadded a400mlaliquotofa3MDMFsolutionof1
(1.20 mmol, 1.5 eq.). The reaction mixture was stirred at room
temperature for 14 h. The product was extracted with H2O/
EtOAc, and the organic phase was washed three times with
H2O. The combined aqueous phase was evaporated in vacuo.
After ﬁltration, nucleoside 3 (226 mg, 0.578 mmol, 72% from
2) was puriﬁed by reverse phase HPLC (0–10 min, 5–20%
CH3CN in H2O, 10–18 min, 20% CH3CN in H2O. Flow rate,
10 ml/min, detected at 260 nm).
1H-NMR (270 MHz, DMSO-
d6) d (p.p.m.) 12.02 (bs, 1H), 9.09 (t, 1H, J ¼ 5.1 Hz), 7.57–
7.54 (m, 2H), 6.47 (s, 1H), 5.07 (bs, 1H), 4.90 (t, 1H, J ¼
5.4 Hz), 4.70 (d, 1H, J ¼ 4.8 Hz), 4.64 (d, 1H, J ¼
4.3 Hz), 4.16 (d, 2H, J ¼ 5.3 Hz), 3.87–3.78 (m, 3H),
3.75–3.45 (m, 2H).
13C-NMR (68 MHz, DMSO-d6) d
(p.p.m.) 163.06, 160.27, 138.44, 137.87, 131.08, 99.72,
84.84, 83.58, 80.29, 78.99, 74.56, 70.75, 66.45, 61.37, 29.73.
HRMS (FAB, 3-NBA matrix) for C15H17O6N2Cl2 (M+1):
calcd., 391.0464; found, 391.0487.
3-(b-D-Ribofuranosyl)-5-[(3-biotinamido-1-propynyl)]-
2-oxo(1H)pyridine (5)
Compound3(71mg,0.18mmol)wasdissolvedin5mlofH2O
and 1 ml of concentrated ammonia solution in a screw-capped
vial, and the solution was stirred for 24 h at room temperature
to yield the deprotected nucleoside 4. After evaporation
in vacuo, the residue was dissolved in 1 ml of dry DMF
together with biotin-N-hydroxysuccinimide (68.2 mg,
0.20 mmol, 1.1 eq.), and the solution was stirred at room
temperature for 2 h. The reaction mixture was then diluted
with H2O, and compound 5 (72 mg, 0.14 mmol, 78% from 3)
was puriﬁed by reverse phase HPLC (0–15 min, 10–40%
CH3CN in H2O, 15–18 min, 50% CH3CN in H2O. Flow
rate, 10 ml/min, detected at 260 nm).
1H-NMR (270 MHz,
DMSO-d6) d (p.p.m.) 11.93 (bs, 1H), 8.27 (t, 1H, J ¼ 5.4 Hz),
7.53 (s, 2H), 6.41 (s, 1H), 6.34 (s, 1H), 5.11 (bs, 1H), 4.92
(t, 1H, J ¼ 5.3 Hz), 4.71 (d, 1H, J ¼ 4.8 Hz), 4.63 (d, 1H,
J ¼ 4.6 Hz), 4.31–4.26 (m, 1H), 4.12–4.09 (m, 1H), 4.04 (d,
2H, J ¼ 5.4 Hz), 3.87–3.78 (m, 3H), 3.62–3.47 (m, 2H),
3.11–3.04 (m, 1H), 2.80 (dd, 1H, J ¼ 5.1 Hz, 12.5 Hz),
2.56 (d, 1H, J ¼ 12.9 Hz), 2.09 (t, 2H, J ¼ 7.4 Hz),
1.62–1.23 (m, 6H).
13C-NMR (68 MHz, DMSO-d6) d
(p.p.m.) 171.56, 162.48, 160.31, 138.57, 137.57, 130.97,
100.15, 86.46, 83.63, 80.34, 78.02, 74.57, 70.80, 61.41,
60.98, 59.13, 55.37, 34.88, 28.52, 28.19, 28.03, 25.15.
HRMS (FAB, 3-NBA matrix) for C23H31O7N4S( M +1):
calcd., 507.1913; found, 507.1937.
3-(b-D-Ribofuranosyl)-5-[(3-biotinamido-1-propynyl)]-
2-oxo(1H)pyridine 50-triphosphate (8, Bio-yTP)
Compound 5 (113 mg, 0.223 mmol) was co-evaporated with
dry pyridine (three times) and dissolved in 2.23 ml of dry
pyridine. To the solution was added 4,40-dimethoxytritylchlo-
ride (79.2 mg, 0.234 mmol, 1.05 eq.), and the solution was
stirred at room temperature for 18 h. The product was
extracted with CH2Cl2/5% NaHCO3, and the aqueous phase
was washed with CH2Cl2. The combined organic phase was
Figure 1. Chemicalstructuresoftheunnaturals–y(A)andv–y(B)pairs,andof
biotinylated-yTP (Bio-yTP) (C).
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80% from 5) was puriﬁed by silica gel column chromatogra-
phy (mobile phase, 0–10% MeOH in CH2Cl2). Compound 6
(144 mg, 0.178 mmol) was co-evaporated with dry pyridine
(three times) and dissolved in 1.8 ml of dry pyridine. To the
solution was added 50 ml of acetic anhydride (0.53 mmol,
3 eq.), and the solution was stirred at room temperature for
12 h. The 20,30-di-O-acetyl derivative of compound 6 was
extracted with CH2Cl2/5% NaHCO3 (aq). The organic phase
was washed twice with 5% NaHCO3 (aq) and once with satu-
rated NaCl, and then was dried over Na2SO4. After the solvent
was removed in vacuo, the residue was co-evaporated with dry
toluene (three times) and dissolved in 890 ml of 80% acetic
acid in H2O. Deprotection of the dimethoxytrityl group was
completed by stirring at room temperature for 2 h. The solvent
was then removed in vacuo, and compound 7 (83 mg,
0.14 mmol, 79% from 6) was puriﬁed by silica gel column
chromatography (mobile phase, 0–10% MeOH in CH2Cl2).
Compound 7 (83 mg, 0.14 mmol) was co-evaporated with
dry pyridine (three times) and dissolved in 560 mlo fd r y
pyridine/dry DMF (1:3, v/v). To the solution was added
154 ml of 1 M 2-chloro-4H-1,3,2-benzodioxaphosphorin-4-
one (12) in dioxane (0.154 mmol, 1.1 eq.). The solution
was stirred at room temperature for 10 min. After the addition
of 140 ml of tri-n-butylamine and 420 ml of 0.5 M bis(tri-n-
butylammonium)pyrophosphate in DMF (0.21 mmol, 1.5 eq.),
the solution was stirred at room temperature for a further
10 min. To the reaction was added 2.8 ml of 1% I2 in
pyridine/H2O (98:2, v/v), and the solution was stirred at
room temperature for 15 min. A 210 ml aliquot of 5% NaHSO3
(aq) was then added and the solvent was removed in vacuo.T o
remove theacetylgroups,theresiduewasdissolvedin14mlof
H2O, and after the solution was stirred at room temperature for
30 min, a concentrated ammonia solution (28 ml) was added.
After stirring at room temperature for 1 h, the solvent was
removed in vacuo. Compound 8 was puriﬁed successively by
anionexchange columnchromatography(DEAE-Sephadex A-
25, 0.05–1 M triethylammonium bicarbonate linear gradient)
and reverse phase HPLC (Synchropak RPP, 0–30% CH3CN in
100 mM triethylammonium acetate).
1H-NMR (270 MHz,
D2O) d (p.p.m.) 7.72 (d, 1H, J ¼ 2.3 Hz), 7.47 (d, 1H, J ¼
2.1 Hz), 4.79 (d, 1H, J ¼ 3.8 Hz), 4.32–4.27 (m, 1H), 4.16–
4.12 (m, 1H), 4.06–3.98 (m, 5H), 3.95 (s, 2H), 3.01 (q, 22H,
J ¼ 7.4 Hz), 2.70 (dd, 1H, J ¼ 5.0 Hz, 13.1 Hz), 2.48 (d, 1H,
J ¼ 13.2 Hz), 2.12 (t, 2H, J ¼ 6.8 Hz), 1.54–1.18 (m, 6H),
1.09 (t, 33H, J ¼ 7.3 Hz).
31P-NMR (109 MHz, D2O) d
(p.p.m.)  9.32 (d, 1P, J ¼ 13.4 Hz),  10.48 (d, 1P, J ¼
18.9 Hz),  22.41 (t, 1P, J ¼ 19.5 Hz). ESI-MS for
C23H32O16N4P3S ([M-H]
 ): calcd., 745.07; found, 744.89.
UV-vis spectrum (in 10 mM sodium phosphate buffer, pH
7.0),lmax ¼ 258nm(e ¼ 1.8 · 10
4),317nm(e ¼ 5.3 · 10
3).
Preparation of templates for T7 transcription
Template DNAs for the anti-(Raf-1) RNA aptamer were
ampliﬁed from an aptamer-encoding vector by PCR, using a
50 end primer [39.45] and a 30 end primer ([24.45] for
the unmodiﬁed aptamer or [24.45s100] for the Bio-y aptamer)
according to the literature (10). The sequences of the primers
were as follows (the T7 promoter region is underlined, and
s denotes 2-amino-6-(2-thienyl)purine): [39.45], 50-GGTA-
ATACGACTCACTATAGGGAGTGGAGGAATTCATCG;
[24.45], 50-GCAGAAGCTTGCTGTCGCTAAGGC; [24.45s-
100], 50-sCAGAAGCTTGCTGTCGCTAAGGC.
T7 transcription for RNA molecules (17mer and
100mer) containing Bio-y
Transcription was carried out in buffer containing 40 mM
Tris–HCl (pH 8.0), 24 mM MgCl2, 5 mM DTT, 2 mM sper-
midine and 0.01% Triton X-100, in the presence of 1 mM of
each NTP, 0.125 mM Bio-yTP, template DNA (2 mM for RNA
17mers and  0.13 mM for Bio-y aptamer, 100mer), and 2.5U/
ml T7 RNA polymerase (Takara), for 6 h at 37 C. To measure
the transcription yields of the RNA 17mers, the reactions
(20 ml) were performed in the presence of 2 mCi [g-
32P]-
GTP, and the products were analyzed on a 20% denaturing
polyacrylamide gel containing 7 M urea. As for the Bio-y
aptamer, the full-length transcripts were puriﬁed by elution
froman8%denaturingpolyacrylamidegelcontaining7Murea.
Analysis of the insertion position of Bio-y in
the 17mer transcript
RNA transcripts (17mer) containing Bio-y or unmodiﬁed y at
position 13 were prepared by T7 transcription using temp35v-
1 as the template, in the presence of 0.125 mM Bio-yTP or
1 mM unmodiﬁed yTP, and were puriﬁed by gel electrophor-
esis. After dephosphorylation by calf intestinal alkaline phos-
phatase (Takara), the RNAs were labeled with
32P at the 50 end
by [g-
32P]ATP (Perkin Elmer) and T4 polynucleotide kinase
(Takara), and were puriﬁed by gel electrophoresis. Alkaline
digestionwas performed in40 mM sodiumcarbonate(pH 9.0),
0.8 mM EDTA and 0.2 mg/ml E.coli tRNAfor 17 min at 90 C.
RNase T1 digestion (0.09 U/ml) was performed in 16 mM
sodium citrate (pH 5.0), 5.5 M urea, 0.8 mM EDTA and
0.2 mg/ml E.coli tRNA for 5 min at 55 C. The digested sam-
ples were analyzed on a 20% polyacrylamide gel containing
7 M urea.
Quartz crystal microbalance (QCM) analysis
QCM experiments were performed on an Afﬁnix-Q apparatus
(13,14) (Initium, Japan). The clean, bare Au (4.9 mm
2)
electrode side of a QCM sensor chip was incubated with an
aqueous solution of 3,30-dithiodipropionic acid (1 mM) at
room temperature for 30 min. Streptavidin was immobilized
on the sensor chip by amine-coupling chemistry. The surfaces
were activated with a mixture of 1-ethyl-3-(3-dimethyl-
aminopropyl)carbodiimide hydrochloride (EDC, 0.2 M) and
N-hydroxysuccinimide (NHS, 0.05 M) for 10 min. A strepta-
vidin solution (100 ml, 200 mg/ml) in 10 mM sodium acetate
(pH 5.2) was applied to the surface for 1 h, and the surface was
treated with a monoethanolamine hydrochloride/NaOH solu-
tion (100 ml, 1 M, pH 8.5) for 10 min to block the remaining
activated groups. After the immobilization of streptavidin, the
frequency decreased by an average of 610 ± 140 Hz. The chip
was then allowed to equilibrate at 22 C, with stirring at
600 r.p.m., in 2 ml phosphate buffer (10.1 mM Na2HPO4
and 1.8 mM KH2PO4) supplemented with 587 mM NaCl,
2.7 mM KCl, 5 mM MgCl2, 2 mM DTT and 0.01%
Tween-20 (Buffer A).
For the Bio-y aptamer immobilization, the aptamer
(60 pmol; 6.7 ml) was injected (time ¼ 0 min) and the
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quency decreased by an average of 400 ± 100 Hz.
Since a frequency decrease (DF) of 1 Hz corresponded to a
mass increase of 30 pg on the electrode (0.049 cm
2), the
concentration (C pmol/cm
2) of immobilized streptavidin
(approx. MW ¼ 60000) or Bio-y aptamer (approx. MW ¼
32000) was calculated using the following formula:
C ¼ (DF · 30)/(MW · 0.049).
To detect the interaction between the aptamer and its target
protein, the RNA-containing buffer was exchanged for 2 ml of
Buffer A, and a BSA solution (25 ml; 20 mg/ml) was added to
prevent non-speciﬁc interactions between RNA and proteins.
After the chip attained equilibrium, a protein solution (20 ml)
containing 64 mM GST-RBD of Raf-1 was injected (time ¼
0 min), and the frequency changes were monitored. For com-
parison, the frequency changes were adjusted to 0 Hz, 15 s
after the protein injection.
Surface plasmon resonance (SPR) analysis
SPR experiments were performed on a BIACORE 3000 appar-
atus (Biacore AB, Sweden) equipped with the BIAcore
3.2 software. Streptavidin was immobilized on the CM5
sensor chip (Research grade), by amine-coupling chemistry.
The immobilization steps were carried out at a ﬂow rate of
5 ml/min in 10 mM HEPES (pH 7.4), 150 mM NaCl, 3 mM
EDTA and 0.005% P20 surfactant. The ﬂow cells were acti-
vated for 7 min with a mixture of NHS (0.05 M) and EDC
(0.2 M), and the streptavidin solution was then injected during
a period of 4 min. The monoethanolamine hydrochloride/
NaOH solution was injected during a period of 7 min, to
block the remaining activated groups. Streptavidin on each
ﬂow cell was 2000 RU on average. The chip was allowed
to equilibrate at 22 C in phosphate buffer (10.1 mM
Na2HPO4 and 1.8 mM KH2PO4) supplemented with 137 mM
NaCl,2.7 mMKCl,5mMMgCl2,2mM DTTand5%glycerol
(Buffer B). For immobilization of the Bio-y aptamer, a 30 nM
solution of the aptamer in Buffer B was injected (time
¼ 0 min) at a ﬂow rate of 10 ml/min for 15 min. About
300 RU of the aptamer were immobilized on the ﬂow cell.
After the chip attained equilibrium in Buffer B, the protein
solutions (640 nM) were injected (time ¼ 0 min) at a ﬂow rate
of 20 ml/min for 2 min. One non-coated or one streptavidin-
coated ﬂow cell was used to monitor the non-speciﬁc binding
of proteins. The RU changes were corrected by using the
signals from the non-coated ﬂow cells. The sensor chip surface
was regenerated with two 10-ml pulses of 6 M urea, followed
by four 10-ml pulses of distilled water, and equilibration in
Buffer B.
RESULTS AND DISCUSSION
Thespeciﬁcityand efﬁciency ofBio-yincorporationinto RNA
were tested by T7 transcription of short DNA templates
(35mer). Bio-yTP, in which a biotin residue is linked to posi-
tion 5 of y through a propynylamine linker, was synthesized
from the ribonucleoside of 5-iodo-y by a six-step reaction
(Figure 2). Transcription of the templates containing v or s
inthe presence of0.125 mMBio-yTP(Figure 3A) yielded full-
length (17mer) transcripts with the site-speciﬁc incorporation
of Bio-y, as indicated by their mobility shift on the gel
(Figure 3B). The transcripts into which Bio-y was incorpo-
rated (lanes 1 and 3) migrated more slowly than the 17mer
transcript consisting of only the natural bases (lane 6).
Although transcription of the v-o rs-containing templates
Figure2. ChemicalsynthesisofBio-yTP.(i)Cl2CHCOCl,NaHCO3,CH 2Cl2,r.t.,3h,81%;(ii)1,Pd(PPh3)4,CuI,Et3N,DMF,r.t.,14h,72%;(iii)NH4OH,r.t.,24h;
(iv) biotin-N-hydroxysuccinimide, DMF, r.t., 2 h, 78% from 3; (v) DMTr-Cl, pyridine, r.t., 18 h, 80%; (vi) (1) (CH3CO)2O, pyridine, r.t., 12 h and (2) 80%
CH3COOH, r.t., 2 h, 79%; and (vii) (1) 2-Chloro-4H-1,3,2-benzodioxaphosphorin-4-one, pyridine, DMF, dioxane, r.t., 10 min; (2) tri-n-butylamine, bis(tri-n-
butylammonium)pyrophosphate, DMF, r.t., 10 min; (3) NH4OH, r.t., 1 h. Abbreviations: DMTr, 4,40-dimethoxytrityl; Ac, acetyl.
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to the misincorporation of natural NTPs opposite v or s in the
template (lanes 2 and 4), the bands corresponding to the mis-
incorporated 17mer were barely detectable in lanes 1 and 3,
and thus, this misincorporation was prevented by the addition
of Bio-yTP. In addition, shifted bands corresponding to the
Bio-y-containing transcripts were not observed upon tran-
scription of the natural template in the presence of Bio-yTP
(lane 5), indicating that Bio-yTP was not incorporated into
RNA opposite the natural bases in the templates.
Furthermore, to conﬁrm the insertion position of Bio-y in
the transcript, we analyzed the sequences of the 17mer tran-
scripts containing Bio-y or y at position 13. The 50-labeled
transcripts containing Bio-yTP or yTP were partially digested
by a treatment with alkali or RNase T1. On the sequencing
ladder of the transcript containing Bio-y (Figure 4), the bands
corresponding to the 13mer to 17mer fragments were shifted,
as compared with the bands resulting from the digestion of the
transcript containing y. These mobility shifts were caused by
the incorporation of Bio-y into the fragments, and clearly
indicate that the Bio-y was site-speciﬁcally incorporated
into position 13 of the transcript, opposite v in the template.
The efﬁciency of transcription mediated by the v–y pair
(Figure 3, lane 1) was slightly higher than that achieved by
the s–y pair (lane 3), and the relative yield (47%) of the Bio-y-
containing transcript from the v-containing template was
higher than that (38%) from the s-containing template. In
contrast, the relative yield (70%) of the truncated product
Figure 4. Sequence analysis of the 17mer transcripts containing Bio-y or y at
position13.The50-labeledtranscripts(N0 ¼ Bio-yory)werepartiallydigested
with alkali (OH
 ) or with RNase T1 (RNase T1), and the digested fragments
and the intact transcripts (Intact) were analyzed on a 20% polyacrylamide gel
containing 7 M urea.
Figure 3. Specific T7 transcription using the unnatural base pairs. (A) Experi-
mental scheme. (B) Gel electrophoresis of transcripts obtained from the tem-
plates(N ¼ v,sorA)inthepresenceorabsenceofBio-yTP.Therelativeyields
ofthefull-lengthtranscripts(17mer)werederivedbycomparisonwiththeyield
of transcripts obtained from transcription of the natural template (N ¼ A;
lane 6), and each yield was averaged from 4 to 5 datasets.
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was slightly lower than that (86%) generated by pausing
before s in the template (lane 3). In addition, this relative
yield (70%) of the 12mer also decreased, in comparison
with the truncated 12mer (103%) obtained from the transcrip-
tion in the absence of Bio-yTP, using the v-containing tem-
plate (lane 2). Thus, decreasing the amounts of truncated
products increases the yield of full-length transcripts contain-
ing Bio-y in the unnatural base pair transcription system.
This site-speciﬁc Bio-y incorporation can be utilized with
RNA molecules with different sequence contexts, although the
transcription efﬁciency depends on the neighboring-base com-
positionofvinthe templates.Transcriptionreactions usingthe
templates containing an AvAo rT vA sequence generated
higher relative yields (59–84%) of the 17mer transcripts
(Figure 5B, lanes 3 and 7). However, the transcription using
the template containing a GvC sequence produced a slightly
lower relative yield (36%) of the transcript (Figure 5B, lane 5).
Furthermore, transcripts containing two Bio-y components
could also be synthesized from the templates containing
two v bases (Figure 5C, lanes 3 and 5). Although the relative
yield (24%) of the transcript containing two adjacent Bio-y
components was relatively low, an adequate amount of
the transcript could be obtained for subsequent biological
experiments.
We used this procedure to transcribe a biotinylated anti-
(Raf-1) RNA aptamer (15) for immobilization on an avidin
support; the immobilized aptamer retained its ability to bind
human Raf-1 speciﬁcally. The RNA aptamer (100mer), in
which Bio-y was incorporated at the 30-terminus, was derived
from its s-containing DNA template prepared by PCR of the
original, unmodiﬁed DNA template using a 30-primer contain-
ing s (Figure 6). The biotinylated RNA aptamer was efﬁciently
immobilized on both sensor chips (Figure 7A and C). The
unmodiﬁed RNA aptamer, in which Bio-y was not incorpo-
rated, did not bind to either sensor chip. The frequency of
QCM decreased upon binding of the modiﬁed RNA aptamer
containing Bio-y (Bio-y aptamer) to the streptavidin on the
QCM plate; 8 ± 2 pmol/cm
2 of Bio-y aptamer were immobi-
lized on the sensor chip containing 6 ± 1 pmol/cm
2 of strep-
tavidin. For the Bio-y aptamer, 300 ± 50 RU were
immobilized on the SPR sensor chip. The interaction of the
immobilized aptamer with its target protein, the Ras binding
domain (RBD) of Raf-1 fused with glutathione S-transferase
(GST-RBD of Raf-1; 640 nM), was detected by the sensors
(Figure 7B and D). The protein bound on the SPR sensor chip
could be removed by a 6 M urea treatment, to regenerate the
sensor chip surface (data not shown). The binding of another
RBD, GST-RBD of RGL (640 nM), to the sensor chip-bound
aptamer was not detected [Figure 7D, (b)], indicating that the
immobilized RNA aptamer retains its speciﬁcity for Raf-1.
This study demonstrates the site-speciﬁc biotinylation of
RNA molecules using a transcription system that included
unnatural base pairs. In this system, the unnatural base pair
between v and Bio-y showed relatively high efﬁciency, as well
as high selectivity, in transcription. Thus, the v–y pair is capa-
ble of efﬁciently incorporating y, modiﬁed with a large func-
tional group, into RNA. DNA templates containing v can be
easily prepared by direct DNA chemical synthesis using the
amidite of v, or by PCR with a v-containing 30-primer and the
original templates. This is very useful, especially for RNA
aptamers, because RNA aptamers contain 50- and 30-constant
regions. In addition, since two Bio-y components can be incor-
porated into one RNA molecule, the immobilization efﬁciency
and the detection sensitivity of the RNA molecule can be
Figure 5. Specific T7 transcription using templates with different sequence
contexts containing one v or two v bases. (A) Experimental scheme. (B) Gel
electrophoresis of transcripts obtained from the templates containing v within
different sequence contexts. (C) Gel electrophoresis of transcripts obtained
from templates containing one v or two v bases. The relative yields of the
full-length transcripts (17mer) were derived by comparison with the yield of
transcripts obtained from transcription of the natural template [lane 10 in (B),
lane 8 in (C)], and each yield was averaged from 3 to 5 datasets.
e129 Nucleic Acids Research, 2005, Vol. 33, No. 15 PAGE 6 OF 8Figure 6. Scheme for Bio-y incorporation into the 30-terminus of the anti-(Raf-1) RNA aptamer.
Figure7.Typicalresponsesofthestreptavidin-coatedsensorchiptotheimmobilizationofthebiotinylatedanti-(Raf-1)aptamer(AandC)anditsinteractionwithits
target Raf-1 (B and D), detected by 27 MHz QCM (A and B) or SPR (C and D). To check for the non-specific binding of proteins, a control RNA (100mer) with
negligible affinity for Raf-1 was immobilized on streptavidin-coated sensor chips [(c) in panel B; (c) and (d) in panel D].
PAGE 7 OF 8 Nucleic Acids Research, 2005, Vol. 33, No. 15 e129increased (16). Thus, this is a practical method for the immob-
ilization and detection of RNA molecules.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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